[PDF] Top 20 Jurisprudencia ambiental de la Unión Europea (Primer semestre 2017)

... with type 2 diabetes (n = 95) at a one-day diabetes educational exposition completed a questionnaire before and after the ...about evidence-based concepts in ... See full document

...  Bockwoldt, D., Staffileno, B. A., Coke, L., Hamilton, R., Fogg, L., Calvin, D., & Quinn, L. (2017). Understanding Experiences of Diabetes Medications Among African Americans Living With Type ... See full document

... Our research particularly revealed the GPs feelings on col- laborative shared care. While some of them disagree on the added value of diabetes educators, many GPs feel some uneasiness regarding the competition ... See full document

... with diabetes and diabetes control, based on the ...attributes. Diabetes type was initially thought to be important because it implies time of life/length of time of having ... See full document

... pre-analytical insight into the data. Next, four researchers conducted the following analytical steps: a) identification of the relevant subjects and texts; b) fragmentation of the text into units of meaning; c) text ... See full document

... with type 2 ...of diabetes care, which unlike hyperglycemia and dyslipidemia can reduce both micro- and macrovascular ...with diabetes than general population, and in most cases its treatment ... See full document

... for people with diabetes [9, ...National Evidence-Based Guideline on Preven- tion, Identification and Management of Foot Complications in Diabetes (Part of the Guidelines on Management ... See full document

... Our findings that online recruitment yielded the greatest number of participants are consistent with some previous research showing this approach to be more time- and/or cost-effective than more traditional methods of ... See full document

... Betatrophin is a secreted protein of 198 aa that promotes â cell proliferation. It is expressed in the, white and brown adipose tissue of mice. In humans, betatrophin is expressed in the liver. Evaluation the potency of ... See full document

... BMI, diabetes duration, LDL-C, and SBP were positively associated with macrovascular and microvascular complications, while TC and TG were positively correlated with macrovascular complica- tions and creatinine ... See full document

... or mimetics and the dipeptidyl peptidase type 4 (DPP4) inhibitors. Being glucose dependant in their action, they protect the diabetic patient against the possible hazardous hypoglycemic side effect of antidiabetic ... See full document

... to type 2 diabetes treatment, given that monotherapies sometimes fail to meet the treatment targets – obtaining a sustained reduction in micro- and macrovascular ...with type 2 ... See full document

... Mutations in the gene encoding SGLT2 result in an autosomal genetic disorder, familial renal glucosuria (FRG). The transmission of this rare disease is thought to be co-dominant with incomplete penetrance. Patients have ... See full document

... noninferiority for change in A 1c at 26 weeks with further effi- cacy and safety evaluated at the same time. Dulaglutide was shown to be noninferior to liraglutide with a between-group A 1c difference of - 0.06% (95% ... See full document

... this being the aggregate effect of pay inflation as measured by the Pay Cost Index (PCI) and the HSCI. This would have seen a 42% uplift in the nominal costs of complications. The effects of applying the HCHS index have ... See full document

... No studies have directly evaluated differences in pioglitazone tolerability between human males and females. Recently the hypothesis that some adverse effects of TZDs could be related to specific interactions between ... See full document

... risk of genital mycotic infections, symptomatic orthostatic BP changes, and a small but clinically important tendency to normoglycemic ketoacidosis. The initial experience from the EMPA-REG studies suggests benefit in ... See full document

... The majority of the sample were male (93, 53.1%) while the female participants was (82, 46.9%). Seventy two percent of the participants’ age was under 45 years old (Figure 1). Most of the participants (45.70%) was ... See full document

... with diabetes by meta-analysis trials, from 1966 to 2009 showed that the involvement of both diabetes and depression, reduced Adherence, poor metabolic control, increasing higher complication rates and ... See full document

... implementation problems on the ground, and the ‘fit’ of the model to local context, skills and resources. The problems identified are not new and have been reported elsewhere, however they provide an important ... See full document